Siemens Healthineers Past Earnings Performance

Past criteria checks 2/6

Siemens Healthineers has been growing earnings at an average annual rate of 4.3%, while the Medical Equipment industry saw earnings growing at 4.3% annually. Revenues have been growing at an average rate of 11.6% per year. Siemens Healthineers's return on equity is 8.6%, and it has net margins of 7%.

Key information

4.3%

Earnings growth rate

1.2%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate11.6%
Return on equity8.6%
Net Margin7.0%
Next Earnings Update07 May 2024

Recent past performance updates

Recent updates

Siemens Healthineers (ETR:SHL) Takes On Some Risk With Its Use Of Debt

Mar 29
Siemens Healthineers (ETR:SHL) Takes On Some Risk With Its Use Of Debt

Siemens Healthineers AG's (ETR:SHL) P/E Still Appears To Be Reasonable

Feb 22
Siemens Healthineers AG's (ETR:SHL) P/E Still Appears To Be Reasonable

The Siemens Healthineers AG (ETR:SHL) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Feb 04
The Siemens Healthineers AG (ETR:SHL) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Is Siemens Healthineers (ETR:SHL) A Risky Investment?

Dec 18
Is Siemens Healthineers (ETR:SHL) A Risky Investment?

Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet

Aug 24
Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet

Siemens Healthineers AG's (ETR:SHL) Intrinsic Value Is Potentially 26% Above Its Share Price

Jun 08
Siemens Healthineers AG's (ETR:SHL) Intrinsic Value Is Potentially 26% Above Its Share Price

Calculating The Fair Value Of Siemens Healthineers AG (ETR:SHL)

Mar 03
Calculating The Fair Value Of Siemens Healthineers AG (ETR:SHL)

Siemens Healthineers (ETR:SHL) Is Increasing Its Dividend To €0.95

Feb 13
Siemens Healthineers (ETR:SHL) Is Increasing Its Dividend To €0.95

It's Unlikely That Siemens Healthineers AG's (ETR:SHL) CEO Will See A Huge Pay Rise This Year

Feb 09
It's Unlikely That Siemens Healthineers AG's (ETR:SHL) CEO Will See A Huge Pay Rise This Year

Is Siemens Healthineers (ETR:SHL) A Risky Investment?

Jan 27
Is Siemens Healthineers (ETR:SHL) A Risky Investment?

Siemens Healthineers' (ETR:SHL) Upcoming Dividend Will Be Larger Than Last Year's

Jan 09
Siemens Healthineers' (ETR:SHL) Upcoming Dividend Will Be Larger Than Last Year's

Siemens Healthineers (ETR:SHL) Has Announced That It Will Be Increasing Its Dividend To €0.95

Dec 18
Siemens Healthineers (ETR:SHL) Has Announced That It Will Be Increasing Its Dividend To €0.95

Siemens Healthineers (ETR:SHL) Is Increasing Its Dividend To €0.95

Nov 17
Siemens Healthineers (ETR:SHL) Is Increasing Its Dividend To €0.95

An Intrinsic Calculation For Siemens Healthineers AG (ETR:SHL) Suggests It's 33% Undervalued

Nov 01
An Intrinsic Calculation For Siemens Healthineers AG (ETR:SHL) Suggests It's 33% Undervalued

Is Now The Time To Put Siemens Healthineers (ETR:SHL) On Your Watchlist?

Oct 01
Is Now The Time To Put Siemens Healthineers (ETR:SHL) On Your Watchlist?

Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet

Aug 05
Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet

Siemens Healthineers (ETR:SHL) Ticks All The Boxes When It Comes To Earnings Growth

Jun 24
Siemens Healthineers (ETR:SHL) Ticks All The Boxes When It Comes To Earnings Growth

Does Siemens Healthineers (ETR:SHL) Have A Healthy Balance Sheet?

Apr 18
Does Siemens Healthineers (ETR:SHL) Have A Healthy Balance Sheet?

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Siemens Healthineers AG's (ETR:SHL) CEO For Now

Feb 08
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Siemens Healthineers AG's (ETR:SHL) CEO For Now

Is Siemens Healthineers (ETR:SHL) Using Too Much Debt?

Jan 16
Is Siemens Healthineers (ETR:SHL) Using Too Much Debt?

I Built A List Of Growing Companies And Siemens Healthineers (ETR:SHL) Made The Cut

Dec 05
I Built A List Of Growing Companies And Siemens Healthineers (ETR:SHL) Made The Cut

Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet

Sep 06
Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet

Siemens Healthineers AG (ETR:SHL) Shares Could Be 40% Below Their Intrinsic Value Estimate

Jul 26
Siemens Healthineers AG (ETR:SHL) Shares Could Be 40% Below Their Intrinsic Value Estimate

We Think Siemens Healthineers (ETR:SHL) Can Stay On Top Of Its Debt

Jun 01
We Think Siemens Healthineers (ETR:SHL) Can Stay On Top Of Its Debt

A Look At The Intrinsic Value Of Siemens Healthineers AG (ETR:SHL)

Apr 20
A Look At The Intrinsic Value Of Siemens Healthineers AG (ETR:SHL)

Siemens Healthineers AG's (ETR:SHL) Stock Is Going Strong: Have Financials A Role To Play?

Mar 12
Siemens Healthineers AG's (ETR:SHL) Stock Is Going Strong: Have Financials A Role To Play?

Key Things To Consider Before Buying Siemens Healthineers AG (ETR:SHL) For Its Dividend

Feb 24
Key Things To Consider Before Buying Siemens Healthineers AG (ETR:SHL) For Its Dividend

Four Days Left To Buy Siemens Healthineers AG (ETR:SHL) Before The Ex-Dividend Date

Feb 09
Four Days Left To Buy Siemens Healthineers AG (ETR:SHL) Before The Ex-Dividend Date

How Much Of Siemens Healthineers AG (ETR:SHL) Do Institutions Own?

Jan 29
How Much Of Siemens Healthineers AG (ETR:SHL) Do Institutions Own?

Estimating The Fair Value Of Siemens Healthineers AG (ETR:SHL)

Jan 14
Estimating The Fair Value Of Siemens Healthineers AG (ETR:SHL)

Should You Use Siemens Healthineers's (ETR:SHL) Statutory Earnings To Analyse It?

Dec 30
Should You Use Siemens Healthineers's (ETR:SHL) Statutory Earnings To Analyse It?

Is Siemens Healthineers (ETR:SHL) Using Too Much Debt?

Dec 15
Is Siemens Healthineers (ETR:SHL) Using Too Much Debt?

Would Shareholders Who Purchased Siemens Healthineers' (ETR:SHL) Stock Year Be Happy With The Share price Today?

Nov 30
Would Shareholders Who Purchased Siemens Healthineers' (ETR:SHL) Stock Year Be Happy With The Share price Today?

Revenue & Expenses Breakdown
Beta

How Siemens Healthineers makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XTRA:SHL Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2321,7791,5193,6271,889
30 Sep 2321,6801,5093,6071,866
30 Jun 2321,6241,6033,6041,877
31 Mar 2321,6091,5193,5631,839
31 Dec 2221,7231,9933,4871,818
30 Sep 2221,7142,0383,4081,785
30 Jun 2220,8781,8693,3241,771
31 Mar 2220,6921,8973,3281,738
31 Dec 2119,1971,7613,0711,625
30 Sep 2117,9971,7272,8171,546
30 Jun 2116,7091,6942,5271,403
31 Mar 2115,0211,5742,2111,329
31 Dec 2014,7411,5422,2071,336
30 Sep 2014,4601,4112,2791,342
30 Jun 2014,7261,4842,3091,362
31 Mar 2014,9831,5622,3281,367
31 Dec 1914,8041,5272,2991,351
30 Sep 1914,5181,5672,2141,328
30 Jun 1914,0801,4352,1971,308
31 Mar 1913,8111,3722,1601,301
31 Dec 1813,5321,2992,1511,287
30 Sep 1813,4291,2652,1531,281
30 Jun 1813,3721,2952,1551,281
31 Mar 1813,3791,3302,1781,261
31 Dec 1713,5481,3272,2241,265
30 Sep 1713,6771,3792,2221,253
30 Sep 1613,5471,3112,2061,145
30 Sep 1512,9361,2772,1091,055

Quality Earnings: SHL has high quality earnings.

Growing Profit Margin: SHL's current net profit margins (7%) are lower than last year (9.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SHL's earnings have grown by 4.3% per year over the past 5 years.

Accelerating Growth: SHL's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: SHL had negative earnings growth (-23.8%) over the past year, making it difficult to compare to the Medical Equipment industry average (-9.8%).


Return on Equity

High ROE: SHL's Return on Equity (8.6%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.